+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hyaluronic Acid Market by End-Use Industry: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5548438
  • Report
  • December 2021
  • Region: Global
  • 174 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Allergan
  • Sanofi
  • Shiseido
  • Smith And Nephew Plc.
The hyaluronic acid market was valued at $1.0 billion in 2020, and is projected to reach $2.1 billion by 2030, growing at a CAGR of 8.1% from 2021 to 2030.



Hyaluronic acid is a chemical that is present in the joints, eyes, and skin. Its basic role is to hold water in the tissue cells, keeping the eyes moist and the knees lubricated. In addition, hyaluronic acid has several commercial and medical application. It is used in dietary supplements, face creams, serums, eye drops, and injections.

The rise in chronic diseases and the rise in the healthcare services are projected to drive the growth of the hyaluronic acid market during the forecast period. Furthermore, increased understanding about beauty and health are two elements that are moving the hyaluronic acid market forward. However, adverse effects associated with treatment or therapy such as redness and itching, as well as an increase in the price of hyaluronic acid products, is expected to hamper the hyaluronic acid market's growth during the forecast period.

Key benefits for stakeholders

  • The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the market from 2021 to 2030 to determine the prevailing opportunities.
  • The study provides a comprehensive analysis of the factors that drive and restrict the growth of the market.
  • Porter’s five forces analysis helps analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.
  • Profiles of leading players operating in the market are provided to understand the competitive scenario.
  • The report provides extensive qualitative insights on the significant segments and regions exhibiting favorable growth.

Key market segments


By End-Use Industry

  • Cosmetic Industry
  • Pharmaceutical Industry
  • Nutraceutical Industry

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe

  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Contipro a.s.
  • Landec Corporation
  • Anmol Chemicals Group
  • Kewpie Corporation
  • Shandong Topscience Biotech Co., Ltd. (Shandong Topscience)
  • Liuzhou Shengqiang Biotech Co.,Ltd.(Shengqiang Biotech)
  • Shijiazhuang Lateen Chemical Co., Ltd.
  • Shandong Focuschem Biotech Co., Ltd.
  • Tiansheng Bio
  • Kikkoman Biochemifa Company

Other players in the market are Allergan, Inc., Salix Pharmaceuticals, Sanofi, Anika Therapeutics, Smith and Nephew Plc, Shiseido, and others
Frequently Asked Questions about the Hyaluronic Acid Market

What is the estimated value of the Hyaluronic Acid Market?

The Hyaluronic Acid Market was estimated to be valued at $1.0 billion in 2020.

What is the growth rate of the Hyaluronic Acid Market?

The growth rate of the Hyaluronic Acid Market is 7.7%, with an estimated value of $2.1 billion by 2030.

What is the forecasted size of the Hyaluronic Acid Market?

The Hyaluronic Acid Market is estimated to be worth $2.1 billion by 2030.

Who are the key companies in the Hyaluronic Acid Market?

Key companies in the Hyaluronic Acid Market include Allergan, Salix Pharmaceuticals (Salix), Sanofi, Anika Therapeutics (Anika) and Shiseido.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan
  • Sanofi
  • Shiseido
  • Smith And Nephew Plc.

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top investment pockets
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. High benefits of hyaluronic acid in cosmetic industry
3.3.1.2. Growing adoption of nonsurgical cosmetic procedures
3.3.2. Restraint
3.3.2.1. Presence of alternatives to hyaluronic acid
3.3.3. Opportunity
3.3.3.1. Technological advancement in hyaluronic acid
3.4. Impact of government regulation on the hyaluronic acid market
3.5. Value Chain Analysis
3.6. Pricing Analysis
3.6.1. Pricing Analysis, by region
3.6.2. Pricing Analysis, by end-use industry
3.7. Patent Analysis, 2012-2020
3.7.1. Patent analysis, by countries
3.7.2. Patent analysis, by applicants
3.7.3. Patent analysis, by inventors
3.8. COVID-19 Impact Analysis
CHAPTER 4: HYALURONIC ACID MARKET, BY END-USE INDUSTRY
4.1. Overview
4.1.1. Market size and forecast
4.2. Cosmetics industry
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Pharmaceutical industry
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Nutraceutical industry
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: HYALURONIC ACID MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by end-use industry
5.2.3. Market size and forecast, by country
5.2.3.1. U.S.
5.2.3.1.1. Market size and forecast, by end-use industry
5.2.3.2. Canada
5.2.3.2.1. Market size and forecast, by end-use industry
5.2.3.3. Mexico
5.2.3.3.1. Market size and forecast, by end-use industry
5.3. Europe
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by end-use industry
5.3.3. Market size and forecast, by country
5.3.3.1. Germany
5.3.3.1.1. Market size and forecast, by end-use industry
5.3.3.2. France
5.3.3.2.1. Market size and forecast, by end-use industry
5.3.3.3. UK
5.3.3.3.1. Market size and forecast, by end-use industry
5.3.3.4. Italy
5.3.3.4.1. Market size and forecast, by end-use industry
5.3.3.5. Rest of Europe
5.3.3.5.1. Market size and forecast, by end-use industry
5.4. Asia-Pacific
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by end-use industry
5.4.3. Market size and forecast, by country
5.4.3.1. China
5.4.3.1.1. Market size and forecast, by end-use industry
5.4.3.2. Japan
5.4.3.2.1. Market size and forecast, by end-use industry
5.4.3.3. India
5.4.3.3.1. Market size and forecast, by end-use industry
5.4.3.4. South Korea
5.4.3.4.1. Market size and forecast, by end-use industry
5.4.3.5. Rest of Asia-Pacific
5.4.3.5.1. Market size and forecast, by end-use industry
5.5. LAMEA
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by end-use industry
5.5.3. Market size and forecast, by country
5.5.3.1. Brazil
5.5.3.1.1. Market size and forecast, by end-use industry
5.5.3.2. Saudi Arabia
5.5.3.2.1. Market size and forecast, by end-use industry
5.5.3.3. South Africa
5.5.3.3.1. Market size and forecast, by end-use industry
5.5.3.4. Rest of LAMEA
5.5.3.4.1. Market size and forecast, by end-use industry
CHAPTER 6: COMPETITIVE LANDSCAPE
6.1. Introduction
6.1.1. Market player positioning, 2020
6.1.2. Competitive heatmap
CHAPTER 7: COMPANY PROFILES
7.1. Contipro a.s.
7.1.1. Company overview
7.1.2. Key executive
7.1.3. Company snapshot
7.1.4. Product portfolio
7.2. Landec
7.2.1. Company overview
7.2.2. Key executive
7.2.3. Company snapshot
7.2.4. Product portfolio
7.2.5. R&D expenditure
7.2.6. Business performance
7.3. Anmol Chemicals Group
7.3.1. Company overview
7.3.2. Key executive
7.3.3. Company snapshot
7.3.4. Product portfolio
7.4. Kewpie Corporation
7.4.1. Company overview
7.4.2. Key executive
7.4.3. Company snapshot
7.4.4. Operating Business Segments
7.4.5. Product portfolio
7.4.6. Business performance
7.5. SHANDONG TOPSCIENCE BIOTECH CO., LTD.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product portfolio
7.6. Liuzhou Shengqiang Biotech Co.,Ltd.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.7. Shijiazhuang lateen chemical co., ltd.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Product portfolio
7.8. Shandong Focuschem Biotech Co., Ltd
7.8.1. Company overview
7.8.2. Key executive
7.8.3. Company snapshot
7.8.4. Product portfolio
7.9. Tiansheng Bio
7.9.1. Company overview
7.9.2. Key executive
7.9.3. Company snapshot
7.9.4. Product portfolio
7.10. Kikkoman Corporation
7.10.1. Company overview
7.10.2. Key executive
7.10.3. Company snapshot
7.10.4. Product portfolioCHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top investment pockets
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. High benefits of hyaluronic acid in cosmetic industry
3.3.1.2. Growing adoption of nonsurgical cosmetic procedures
3.3.2. Restraint
3.3.2.1. Presence of alternatives to hyaluronic acid
3.3.3. Opportunity
3.3.3.1. Technological advancement in hyaluronic acid
3.4. Impact of government regulation on the hyaluronic acid market
3.5. Value Chain Analysis
3.6. Pricing Analysis
3.6.1. Pricing Analysis, by region
3.6.2. Pricing Analysis, by end-use industry
3.7. Patent Analysis, 2012-2020
3.7.1. Patent analysis, by countries
3.7.2. Patent analysis, by applicants
3.7.3. Patent analysis, by inventors
3.8. COVID-19 Impact Analysis
CHAPTER 4: HYALURONIC ACID MARKET, BY END-USE INDUSTRY
4.1. Overview
4.1.1. Market size and forecast
4.2. Cosmetics industry
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Pharmaceutical industry
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Nutraceutical industry
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: HYALURONIC ACID MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by end-use industry
5.2.3. Market size and forecast, by country
5.2.3.1. U.S.
5.2.3.1.1. Market size and forecast, by end-use industry
5.2.3.2. Canada
5.2.3.2.1. Market size and forecast, by end-use industry
5.2.3.3. Mexico
5.2.3.3.1. Market size and forecast, by end-use industry
5.3. Europe
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by end-use industry
5.3.3. Market size and forecast, by country
5.3.3.1. Germany
5.3.3.1.1. Market size and forecast, by end-use industry
5.3.3.2. France
5.3.3.2.1. Market size and forecast, by end-use industry
5.3.3.3. UK
5.3.3.3.1. Market size and forecast, by end-use industry
5.3.3.4. Italy
5.3.3.4.1. Market size and forecast, by end-use industry
5.3.3.5. Rest of Europe
5.3.3.5.1. Market size and forecast, by end-use industry
5.4. Asia-Pacific
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by end-use industry
5.4.3. Market size and forecast, by country
5.4.3.1. China
5.4.3.1.1. Market size and forecast, by end-use industry
5.4.3.2. Japan
5.4.3.2.1. Market size and forecast, by end-use industry
5.4.3.3. India
5.4.3.3.1. Market size and forecast, by end-use industry
5.4.3.4. South Korea
5.4.3.4.1. Market size and forecast, by end-use industry
5.4.3.5. Rest of Asia-Pacific
5.4.3.5.1. Market size and forecast, by end-use industry
5.5. LAMEA
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by end-use industry
5.5.3. Market size and forecast, by country
5.5.3.1. Brazil
5.5.3.1.1. Market size and forecast, by end-use industry
5.5.3.2. Saudi Arabia
5.5.3.2.1. Market size and forecast, by end-use industry
5.5.3.3. South Africa
5.5.3.3.1. Market size and forecast, by end-use industry
5.5.3.4. Rest of LAMEA
5.5.3.4.1. Market size and forecast, by end-use industry
CHAPTER 6: COMPETITIVE LANDSCAPE
6.1. Introduction
6.1.1. Market player positioning, 2020
6.1.2. Competitive heatmap
CHAPTER 7: COMPANY PROFILES
7.1. Contipro a.s.
7.1.1. Company overview
7.1.2. Key executive
7.1.3. Company snapshot
7.1.4. Product portfolio
7.2. Landec
7.2.1. Company overview
7.2.2. Key executive
7.2.3. Company snapshot
7.2.4. Product portfolio
7.2.5. R&D expenditure
7.2.6. Business performance
7.3. Anmol Chemicals Group
7.3.1. Company overview
7.3.2. Key executive
7.3.3. Company snapshot
7.3.4. Product portfolio
7.4. Kewpie Corporation
7.4.1. Company overview
7.4.2. Key executive
7.4.3. Company snapshot
7.4.4. Operating Business Segments
7.4.5. Product portfolio
7.4.6. Business performance
7.5. SHANDONG TOPSCIENCE BIOTECH CO., LTD.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product portfolio
7.6. Liuzhou Shengqiang Biotech Co.,Ltd.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.7. Shijiazhuang lateen chemical co., ltd.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Product portfolio
7.8. Shandong Focuschem Biotech Co., Ltd
7.8.1. Company overview
7.8.2. Key executive
7.8.3. Company snapshot
7.8.4. Product portfolio
7.9. Tiansheng Bio
7.9.1. Company overview
7.9.2. Key executive
7.9.3. Company snapshot
7.9.4. Product portfolio
7.10. Kikkoman Corporation
7.10.1. Company overview
7.10.2. Key executive
7.10.3. Company snapshot
7.10.4. Product portfolio
List of Tables
TABLE 01. HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 02. HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 03. HYALURONIC ACID MARKET, FOR COSMETICS INDUSTRY, BY REGION, 2020-2030 (TONS)
TABLE 04. HYALURONIC ACID MARKET FOR COSMETICS INDUSTRY, BY REGION, 2020-2030 ($MILLION)
TABLE 05. HYALURONIC ACID MARKET, FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2020-2030 (TONS)
TABLE 06. HYALURONIC ACID MARKET, FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2020-2030 ($MILLION)
TABLE 07. HYALURONIC ACID MARKET, FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2020-2030 (TONS)
TABLE 08. HYALURONIC ACID MARKET, FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2020-2030 ($MILLION)
TABLE 09. HYALURONIC ACID MARKET, BY REGION, 2020-2030 (TONS)
TABLE 10. HYALURONIC ACID MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 11. NORTH AMERICA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 12. NORTH AMERICA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 13. NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY, 2020-2030 (TONS)
TABLE 14. NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 15. U.S. HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 16. U.S. HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 17. CANADA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 18. CANADA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 19. MEXICO HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 20. MEXICO HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 21. EUROPE HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 22. EUROPE HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 23. EUROPE HYALURONIC ACID MARKET, BY COUNTRY, 2020-2030 (TONS)
TABLE 24. EUROPE HYALURONIC ACID MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 25. GERMANY HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 26. GERMANY HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 27. FRANCE HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 28. FRANCE HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 29. UK HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 30. UK HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 31. ITALY HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 32. ITALY HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 33. REST OF EUROPE HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 34. REST OF EUROPE HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 35. ASIA-PACIFIC HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 36. ASIA-PACIFIC HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 37. ASIA-PACIFIC HYALURONIC ACID MARKET, BY COUNTRY, 2020-2030 (TONS)
TABLE 38. ASIA-PACIFIC HYALURONIC ACID MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 39. CHINA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 40. CHINA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 41. JAPAN HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 42. JAPAN HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 43. INDIA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 44. INDIA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 45. SOUTH KOREA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 46. SOUTH KOREA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 48. REST OF ASIA-PACIFIC HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 49. LAMEA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 50. LAMEA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 51. LAMEA HYALURONIC ACID MARKET, BY COUNTRY, 2020-2030 (TONS)
TABLE 52. LAMEA HYALURONIC ACID MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 53. BRAZIL HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 54. BRAZIL HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 55. SAUDI ARABIA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 56. SAUDI ARABIA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 57. SOUTH AFRICA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 58. SOUTH AFRICA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 59. REST OF LAMEA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 60. REST OF LAMEA HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 61. CONTIPRO: KEY EXECUTIVES
TABLE 62. CONTIPRO: COMPANY SNAPSHOT
TABLE 63. CONTIPRO: PRODUCT PORTFOLIO
TABLE 64. LANDEC: KEY EXECUTIVES
TABLE 65. LANDEC: COMPANY SNAPSHOT
TABLE 66. LANDEC: PRODUCT PORTFOLIO
TABLE 67. LANDEC: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 68. LANDEC: NET SALES, 2018-2020 ($MILLION)
TABLE 69. ANMOL CHEMICALS: KEY EXECUTIVES
TABLE 70. ANMOL CHEMICALS: COMPANY SNAPSHOT
TABLE 71. ANMOL CHEMICALS: PRODUCT PORTFOLIO
TABLE 72. KEWPIE: KEY EXECUTIVES
TABLE 73. KEWPIE: COMPANY SNAPSHOT
TABLE 74. KEWPIE: OPERATING BUSINESS SEGMENTS
TABLE 75. KEWPIE: PRODUCT PORTFOLIO
TABLE 76. KEWPIE: NET SALES, 2018-2020 ($MILLION)
TABLE 77. SHANDONG TOPSCIENCE: COMPANY SNAPSHOT
TABLE 78. SHANDONG TOPSCIENCE: PRODUCT PORTFOLIO
TABLE 79. SHENGQIANG BIOTECH: COMPANY SNAPSHOT
TABLE 80. SHENGQIANG BIOTECH: PRODUCT PORTFOLIO
TABLE 81. LATEEN CHEMICAL: COMPANY SNAPSHOT
TABLE 82. LATEEN CHEMICAL: PRODUCT PORTFOLIO
TABLE 83. FOCUSCHEM BIOTECH: KEY EXECUTIVES
TABLE 84. FOCUSCHEM BIOTECH: COMPANY SNAPSHOT
TABLE 85. FOCUSCHEM BIOTECH: PRODUCT PORTFOLIO
TABLE 86. TS-BIOTECH: KEY EXECUTIVES
TABLE 87. TS-BIOTECH: COMPANY SNAPSHOT
TABLE 88. TS-BIOTECH: PRODUCT PORTFOLIO
TABLE 89. KIKKOMAN BIOCHEMIFA: KEY EXECUTIVES
TABLE 90. KIKKOMAN BIOCHEMIFA: COMPANY SNAPSHOT
TABLE 91. KIKKOMAN BIOCHEMIFA: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. HYALURONIC ACID MARKET SNAPSHOT, BY SEGMENTATION, 2021-2030
FIGURE 03. HYALURONIC ACID MARKET SNAPSHOT, BY REGION, 2021-2030
FIGURE 04. TOP INVESTMENT POCKETS, BY COUNTRY
FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE BARGAINING POWER OF BUYERS
FIGURE 07. HIGH THREAT OF SUBSTITUTES
FIGURE 08. HIGH THREAT OF NEW ENTRANTS
FIGURE 09. MODERATE INTENSITY OF RIVALRY
FIGURE 10. HYALURONIC ACID MARKET: MARKET DYNAMICS
FIGURE 11. HYALURONIC ACID MARKET: VALUE CHAIN ANALYSIS
FIGURE 12. PRICING ANALYSIS, BY REGION, 2020-2030
FIGURE 13. PRICING ANALYSIS, BY END-USE INDUSTRY, 2020-2030
FIGURE 14. HYALURONIC ACID MARKET: PATENT ANALYSIS, BY COUNTRIES, 2012-2020
FIGURE 15. HYALURONIC ACID MARKET: PATENT ANALYSIS, BY APPLICANTS, 2012-2020
FIGURE 16. HYALURONIC ACID MARKET: PATENT ANALYSIS, BY INVENTORS, 2012-2020
FIGURE 17. HYALURONIC ACID MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF HYALURONIC ACID MARKET, FOR COSMETICS INDUSTRY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF HYALURONIC ACID MARKET, FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF HYALURONIC ACID MARKET, FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. U.S. HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 22. CANADA HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 23. MEXICO HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 24. GERMANY HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 25. FRANCE HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 26. UK HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 27. ITALY HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 28. REST OF EUROPE HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 29. CHINA HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 30. JAPAN HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 31. INDIA HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 32. SOUTH KOREA HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 33. REST OF ASIA-PACIFIC HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 34. BRAZIL HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 35. SAUDI ARABIA HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 36. SOUTH AFRICA HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 37. REST OF LAMEA HYALURONIC ACID MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 38. MARKET PLAYER POSITIONING, 2020
FIGURE 39. HYALURONIC ACID MARKET: COMPETITIVE HEATMAP
FIGURE 40. LANDEC: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 41. LANDEC: NET SALES, 2018-2020 ($MILLION)
FIGURE 42. LANDEC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43. KEWPIE: NET SALES, 2018-2020 ($MILLION)
FIGURE 44. KEWPIE: REVENUE SHARE BY SEGMENT, 2020 (%)
Note: Product cover images may vary from those shown
  • Allergan
  • Salix Pharmaceuticals (Salix)
  • Sanofi
  • Anika Therapeutics (Anika)
  • Smith And Nephew Plc.
  • Shiseido
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...